QQQ   361.50 (+0.97%)
AAPL   171.94 (+0.73%)
MSFT   317.34 (+1.18%)
META   307.34 (+1.11%)
GOOGL   132.63 (+0.24%)
AMZN   128.14 (+1.71%)
TSLA   250.86 (+1.82%)
NVDA   439.00 (+1.88%)
NIO   9.16 (+2.81%)
BABA   87.38 (+2.15%)
AMD   103.97 (+1.18%)
T   15.02 (+0.07%)
F   12.65 (+0.72%)
MU   67.10 (+2.91%)
CGC   0.84 (+2.64%)
GE   112.23 (-0.10%)
DIS   80.78 (+0.81%)
AMC   7.92 (+1.67%)
PFE   32.39 (+0.93%)
PYPL   59.06 (+1.51%)
NFLX   381.12 (+1.26%)
QQQ   361.50 (+0.97%)
AAPL   171.94 (+0.73%)
MSFT   317.34 (+1.18%)
META   307.34 (+1.11%)
GOOGL   132.63 (+0.24%)
AMZN   128.14 (+1.71%)
TSLA   250.86 (+1.82%)
NVDA   439.00 (+1.88%)
NIO   9.16 (+2.81%)
BABA   87.38 (+2.15%)
AMD   103.97 (+1.18%)
T   15.02 (+0.07%)
F   12.65 (+0.72%)
MU   67.10 (+2.91%)
CGC   0.84 (+2.64%)
GE   112.23 (-0.10%)
DIS   80.78 (+0.81%)
AMC   7.92 (+1.67%)
PFE   32.39 (+0.93%)
PYPL   59.06 (+1.51%)
NFLX   381.12 (+1.26%)
QQQ   361.50 (+0.97%)
AAPL   171.94 (+0.73%)
MSFT   317.34 (+1.18%)
META   307.34 (+1.11%)
GOOGL   132.63 (+0.24%)
AMZN   128.14 (+1.71%)
TSLA   250.86 (+1.82%)
NVDA   439.00 (+1.88%)
NIO   9.16 (+2.81%)
BABA   87.38 (+2.15%)
AMD   103.97 (+1.18%)
T   15.02 (+0.07%)
F   12.65 (+0.72%)
MU   67.10 (+2.91%)
CGC   0.84 (+2.64%)
GE   112.23 (-0.10%)
DIS   80.78 (+0.81%)
AMC   7.92 (+1.67%)
PFE   32.39 (+0.93%)
PYPL   59.06 (+1.51%)
NFLX   381.12 (+1.26%)
QQQ   361.50 (+0.97%)
AAPL   171.94 (+0.73%)
MSFT   317.34 (+1.18%)
META   307.34 (+1.11%)
GOOGL   132.63 (+0.24%)
AMZN   128.14 (+1.71%)
TSLA   250.86 (+1.82%)
NVDA   439.00 (+1.88%)
NIO   9.16 (+2.81%)
BABA   87.38 (+2.15%)
AMD   103.97 (+1.18%)
T   15.02 (+0.07%)
F   12.65 (+0.72%)
MU   67.10 (+2.91%)
CGC   0.84 (+2.64%)
GE   112.23 (-0.10%)
DIS   80.78 (+0.81%)
AMC   7.92 (+1.67%)
PFE   32.39 (+0.93%)
PYPL   59.06 (+1.51%)
NFLX   381.12 (+1.26%)
LON:AMS

Advanced Medical Solutions Group (AMS) Competitors

GBX 199
+0.20 (+0.10%)
(As of 02:21 PM ET)
Compare
Today's Range
192.20
200.52
50-Day Range
177.73
258
52-Week Range
165.60
304.50
Volume
81,738 shs
Average Volume
369,094 shs
Market Capitalization
£432.25 million
P/E Ratio
2,211.11
Dividend Yield
1.01%
Price Target
GBX 293

AMS vs. TSTL, BVC, AVCT, AMYT, HZD, SLN, NIOX, BMK, CSRT, and MXCT

Should you be buying Advanced Medical Solutions Group stock or one of its competitors? The main competitors of Advanced Medical Solutions Group include Tristel (TSTL), BATM Advanced Communications (BVC), Avacta Group (AVCT), Amryt Pharma (AMYT), Horizon Discovery Group plc (HZD.L) (HZD), Silence Therapeutics (SLN), NIOX Group (NIOX), Benchmark (BMK), Consort Medical plc (CSRT.L) (CSRT), and MaxCyte (MXCT). These companies are all part of the "medical" sector.

Advanced Medical Solutions Group vs.

Advanced Medical Solutions Group (LON:AMS) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, institutional ownership, media sentiment, valuation, dividends, earnings and profitability.

Advanced Medical Solutions Group has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.44, meaning that its share price is 56% less volatile than the S&P 500.

Advanced Medical Solutions Group has a net margin of 15.23% compared to Tristel's net margin of 10.21%. Tristel's return on equity of 12.21% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Advanced Medical Solutions Group15.23% 8.49% 5.23%
Tristel 10.21%12.21%8.84%

Advanced Medical Solutions Group currently has a consensus target price of GBX 293, indicating a potential upside of 47.38%. Tristel has a consensus target price of GBX 390, indicating a potential downside of 8.77%. Given Advanced Medical Solutions Group's higher possible upside, equities analysts plainly believe Advanced Medical Solutions Group is more favorable than Tristel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Advanced Medical Solutions Group
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Tristel
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Advanced Medical Solutions Group has higher revenue and earnings than Tristel. Advanced Medical Solutions Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Advanced Medical Solutions Group£129.11M3.34£19.67M£0.092,208.89
Tristel£33.46M6.04£3.42M£0.076,107.14

66.6% of Advanced Medical Solutions Group shares are held by institutional investors. Comparatively, 51.4% of Tristel shares are held by institutional investors. 2.7% of Advanced Medical Solutions Group shares are held by insiders. Comparatively, 6.0% of Tristel shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Advanced Medical Solutions Group had 5 more articles in the media than Tristel. MarketBeat recorded 5 mentions for Advanced Medical Solutions Group and 0 mentions for Tristel. Advanced Medical Solutions Group's average media sentiment score of 1.25 beat Tristel's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company Overall Sentiment
Advanced Medical Solutions Group Positive
Tristel Neutral

Advanced Medical Solutions Group pays an annual dividend of GBX 2 per share and has a dividend yield of 1.0%. Tristel pays an annual dividend of GBX 7 per share and has a dividend yield of 1.6%. Advanced Medical Solutions Group pays out 2,222.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Tristel pays out 10,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Advanced Medical Solutions Group received 15 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 49.54% of users gave Advanced Medical Solutions Group an outperform vote.

CompanyUnderperformOutperform
Advanced Medical Solutions GroupOutperform Votes
163
49.54%
Underperform Votes
166
50.46%
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%

Summary

Advanced Medical Solutions Group beats Tristel on 11 of the 19 factors compared between the two stocks.


Get Advanced Medical Solutions Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMS vs. The Competition

MetricAdvanced Medical Solutions GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£431.81M£3.01B£4.56B£1.40B
Dividend Yield1.14%1.89%2.52%12.49%
P/E Ratio2,208.89432.51152.481,578.16
Price / Sales3.34215.852,939.2853,858.51
Price / Cash7.87116.8494.5627.25
Price / Book1.784.713.772.56
Net Income£19.67M£129.89M£122.74M£204.75M
7 Day Performance3.22%-1.81%1.59%3.87%
1 Month Performance-21.11%-5.67%-1.82%6.67%
1 Year Performance-19.19%0.05%9.78%7.88%

Advanced Medical Solutions Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TSTL
Tristel
0 of 5 stars
GBX 415
+2.5%
GBX 390
-6.0%
+26.9%£196.34M£33.46M5,928.57194
BVC
BATM Advanced Communications
0 of 5 stars
GBX 28.85
-2.2%
N/A-2.5%£125.80M£118.78M2,800.00949Gap Down
AVCT
Avacta Group
0 of 5 stars
GBX 130
+22.6%
N/A+11.4%£363.12M£9.65M-812.50120Gap Up
High Trading Volume
AMYT
Amryt Pharma
0 of 5 stars
N/AN/AN/A£457.11M£210.24M-4.332,020
HZD
Horizon Discovery Group plc (HZD.L)
0 of 5 stars
N/AN/A+0.0%£302.98M£54.63M-33.55416
SLN
Silence Therapeutics
0 of 5 stars
GBX 535
-0.9%
N/AN/A£480.35M£11.35M-11.0174News Coverage
High Trading Volume
NIOX
NIOX Group
1.0805 of 5 stars
GBX 70
+1.2%
N/A+87.1%£294.31M£31.30M2,333.3392Analyst Report
News Coverage
BMK
Benchmark
0 of 5 stars
GBX 38.80
-1.0%
N/A-3.9%£286.87M£175.89M-1,293.33847Gap Up
CSRT
Consort Medical plc (CSRT.L)
0 of 5 stars
GBX 1,010
+0.5%
N/A+0.0%£504.60M£298.60M127.85N/A
MXCT
MaxCyte
1.7845 of 5 stars
GBX 267.50
-1.8%
GBX 1,060
+296.3%
-56.1%£276.86M£40.69M-1,070.00125News Coverage

Related Companies and Tools

This page (LON:AMS) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -